Nitorum Capital, L.P. United Therapeutics Corp Transaction History
Nitorum Capital, L.P.
- $547 Million
- Q1 2025
A detailed history of Nitorum Capital, L.P. transactions in United Therapeutics Corp stock. As of the latest transaction made, Nitorum Capital, L.P. holds 78,047 shares of UTHR stock, worth $23.2 Million. This represents 4.4% of its overall portfolio holdings.
Number of Shares
78,047
Previous 95,420
18.21%
Holding current value
$23.2 Million
Previous $33.7 Million
28.54%
% of portfolio
4.4%
Previous 4.92%
Shares
7 transactions
Others Institutions Holding UTHR
# of Institutions
733Shares Held
43.3MCall Options Held
124KPut Options Held
122K-
Black Rock Inc. New York, NY5.47MShares$1.63 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.46MShares$1.33 Billion0.03% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.68MShares$796 Million13.34% of portfolio
-
State Street Corp Boston, MA2.23MShares$664 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.11MShares$627 Million1.04% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $13.5B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...